These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 23759172

  • 1. Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study.
    Brunoni AR, Kemp AH, Dantas EM, Goulart AC, Nunes MA, Boggio PS, Mill JG, Lotufo PA, Fregni F, Benseñor IM.
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1937-49. PubMed ID: 23759172
    [Abstract] [Full Text] [Related]

  • 2. The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial.
    Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF, Goulart A, Boggio PS, Lotufo PA, Benseñor IM, Fregni F.
    JAMA Psychiatry; 2013 Apr; 70(4):383-91. PubMed ID: 23389323
    [Abstract] [Full Text] [Related]

  • 3. Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement.
    Glassman AH, Bigger JT, Gaffney M, Van Zyl LT.
    Arch Gen Psychiatry; 2007 Sep; 64(9):1025-31. PubMed ID: 17768267
    [Abstract] [Full Text] [Related]

  • 4. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
    Brunoni AR, Machado-Vieira R, Zarate CA, Vieira EL, Vanderhasselt MA, Nitsche MA, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL.
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
    [Abstract] [Full Text] [Related]

  • 5. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.
    Brunoni AR, Machado-Vieira R, Zarate CA, Vieira EL, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan 02; 56():91-6. PubMed ID: 25172025
    [Abstract] [Full Text] [Related]

  • 6. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
    Brunoni AR, Kemp AH, Shiozawa P, Cordeiro Q, Valiengo LC, Goulart AC, Coprerski B, Lotufo PA, Brunoni D, Perez AB, Fregni F, Benseñor IM.
    Eur Neuropsychopharmacol; 2013 Nov 02; 23(11):1530-40. PubMed ID: 23615118
    [Abstract] [Full Text] [Related]

  • 7. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
    Hedayati SS, Gregg LP, Carmody T, Jain N, Toups M, Rush AJ, Toto RD, Trivedi MH.
    JAMA; 2017 Nov 21; 318(19):1876-1890. PubMed ID: 29101402
    [Abstract] [Full Text] [Related]

  • 8. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
    Glassman AH, Bigger JT, Gaffney M, Shapiro PA, Swenson JR.
    Arch Gen Psychiatry; 2006 Mar 21; 63(3):283-8. PubMed ID: 16520433
    [Abstract] [Full Text] [Related]

  • 9. Comparison of blinding effectiveness between sham tDCS and placebo sertraline in a 6-week major depression randomized clinical trial.
    Brunoni AR, Schestatsky P, Lotufo PA, Benseñor IM, Fregni F.
    Clin Neurophysiol; 2014 Feb 21; 125(2):298-305. PubMed ID: 23994192
    [Abstract] [Full Text] [Related]

  • 10. Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial.
    Jain N, Wan F, Kothari M, Adelodun A, Ware J, Sarode R, Hedayati SS.
    BMC Nephrol; 2019 Oct 29; 20(1):395. PubMed ID: 31664940
    [Abstract] [Full Text] [Related]

  • 11. Physical Exercise for Late-Life Depression: Effects on Heart Rate Variability.
    Toni G, Belvederi Murri M, Piepoli M, Zanetidou S, Cabassi A, Squatrito S, Bagnoli L, Piras A, Mussi C, Senaldi R, Menchetti M, Zocchi D, Ermini G, Ceresini G, Tripi F, Rucci P, Alexopoulos GS, Amore M, SEEDS study group.
    Am J Geriatr Psychiatry; 2016 Nov 29; 24(11):989-997. PubMed ID: 27660194
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial.
    Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R.
    J Clin Psychopharmacol; 2003 Dec 29; 23(6):553-62. PubMed ID: 14624185
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
    Kircanski K, Williams LM, Gotlib IH.
    Depress Anxiety; 2019 Jan 29; 36(1):63-71. PubMed ID: 30311742
    [Abstract] [Full Text] [Related]

  • 16. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G, Duffy L, Ades A, Araya R, Button KS, Churchill R, Croudace T, Derrick C, Dixon P, Dowrick C, Gilbody S, Hollingworth W, Jones V, Kendrick T, Kessler D, Kounali D, Lanham P, Malpass A, Peters TJ, Riozzie D, Robinson J, Sharp D, Thomas L, Welton NJ, Wiles N, Lewis G.
    Trials; 2017 Oct 24; 18(1):496. PubMed ID: 29065916
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.
    Brunoni AR, Machado-Vieira R, Zarate CA, Valiengo L, Vieira EL, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL.
    Psychopharmacology (Berl); 2014 Apr 24; 231(7):1315-23. PubMed ID: 24150249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.